Embedding equity, diversity and inclusion processes within clinical trials and health and social care research
Authors:
Open Access
Abstract
The lack of diverse and inclusive clinical research populations fuels health inequalities in the UK, and there is an urgent need to reverse this. This communication provides a practical framework for positive action to integrate equity, diversity and inclusion (EDI) processes into clinical research design, protocols and implementation and to establish accountable clinical research systems that are trustworthy to the public and accessible to diverse communities. This framework is a consensus-based guide developed by the Equality, Diversity and Inclusion working group of the National Institute for Health and Care Research’s (NIHR’s) Clinical Research Network in North West London. This work involved analysing challenges to integrating EDI within the clinical research process, such as clinical trial protocols as directed by industry sponsors and National Health Service investigator teams. It aligns with the UK government’s clinical research strategy and NIHR’s INCLUDE project. It advises an interconnected approach to embedding EDI throughout the clinical research lifecycle. By following this framework, we aspire to guide clinical research towards a more equitable, inclusive and representative model that better serves the needs of all populations.Keywords
This publication has 23 references indexed in Scilit:
- Increasing diversity and inclusion in nephrology clinical trialsNature Reviews Nephrology, 2023
- Decentralised clinical trials: ethical opportunities and challengesThe Lancet Digital Health, 2023
- Decentralised elements in clinical trials: recommendations from the European Medicines Regulatory NetworkThe Lancet, 2023
- FDA to require diversity plan for clinical trialsNature, 2023
- Health data poverty: an assailable barrier to equitable digital health careThe Lancet Digital Health, 2021
- Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018JAMA, 2020
- Clinical development success rates for investigational drugsNature Biotechnology, 2014
- Reporting and representation of ethnic minorities in cardiovascular trials: A systematic reviewAmerican Heart Journal, 2013
- Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trialThe Lancet, 2005
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996